Information therapy using inaudible sounds for substance use disorders
Phase 1
Recruiting
- Conditions
- Substance use disorders
- Registration Number
- JPRN-UMIN000025637
- Lead Sponsor
- ational Center of Neurology and Psychiatry
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
-In case they have history of developmental disorder, bipolar disorder or schizophrenia. -In case they are evaluated as insufficient for providing informed consent -In case they are evaluated as not appropriate for enrolling in the study by attending physician.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What neurobiological mechanisms underlie inaudible sound therapy for substance use disorders?
How does auditory information therapy compare to standard-of-care pharmacotherapies for opioid/alcohol use disorders?
Which biomarkers (e.g., dopamine receptor polymorphisms) predict response to inaudible sound-based interventions?
What are the safety profiles and management strategies for auditory information therapy in Phase I trials?
What non-invasive neuromodulation approaches (e.g., TMS, neurofeedback) synergize with inaudible sound therapy for addiction?